Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial
Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment